Mesothelioma Legal News

Mesothelioma in southern Nevada likely result of asbestos in environment

Malignant mesothelioma has been found at higher than expected levels in women and in individuals younger than 55 years old in the southern Nevada counties of Clark and Nye, likewise in the same region carcinogenic mineral fibers including actinolite as…

Mesothelioma in southern Nevada likely result of asbestos in environment

Malignant mesothelioma has been found at higher than expected levels in women and in individuals younger than 55 years old in the southern Nevada counties of Clark and Nye, likewise in the same region carcinogenic mineral fibers including actinolite as…

Mesothelioma in southern Nevada likely result of asbestos in environment

Malignant mesothelioma has been found at higher than expected levels in women and in individuals younger than 55 years old in the southern Nevada counties of Clark and Nye, likewise in the same region carcinogenic mineral fibers including actinolite as…

Government u-turn sees 100 per cent compensation guaranteed for mesothelioma sufferers

Ministers have abandoned much-criticised payouts worth only 80 per cent of average civil claims, which were agreed in a voluntary deal struck with insurance companies. The cut was heavily criticised when the Mesothelioma Bill passed last year, when a C…

Victims of mesothelioma across Medway Towns to get full compensation after new plans from the DWP

Victims of mesothelioma, a cancer often linked to asbestos, who have been unable to get compensation because they cannot trace their insurer, can now make a fresh 100% claim. The major breakthrough in the fight to get damages is a major victory for Cha…

Peritoneal Cancer Therapeutics Pipeline Review H1 2015 Market Research Report

The report ” Peritoneal Cancer – Pipeline Review, H1 2015 ” provides comprehensive information on the therapeutic development for peritoneal cancer . Primary peritoneal cancer is a relatively rare cancer that develops most commonly in women.

Polaris Group Announces Treatment Of First Patient In Phase 1 Study …

In addition to a global Phase 3 study in hepatocellular carcinoma featuring ADI-PEG 20 as a monotherapy, Polaris Group is currently conducting clinical trials on ADI-PEG 20 in combination with cisplatin in melanoma and ovarian cancer, in combination wi…